BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation
- 1 March 2015
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (3) , 1303-1309
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of University
- Alzheimer's Association (NIRG173407)
This publication has 48 references indexed in Scilit:
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal NetworkNeuron, 2010
- Targeting p38 MAPK pathway for the treatment of Alzheimer's diseaseNeuropharmacology, 2010
- Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented SubjectsPLOS ONE, 2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- The Ubiquitin Ligase RPM-1 and the p38 MAPK PMK-3 Regulate AMPA Receptor TraffickingPLOS ONE, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic DysfunctionJournal of Neuroscience, 2008
- Modulation of NMDA receptors by AKT kinaseNeurochemistry International, 2006
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991